Hepatopulmonary syndrome secondary to metabolic associated fatty liver disease in childhood — novel treatment with growth hormone replacement therapy: a case report and systematic review of literatureYunsoo Choe, Choong Ho Shin, Yun Jeong Lee et al.|Frontiers in Endocrinology|2024Cited by 2
SAT-387 Trajectories of serum bile acid levels and their determinants in progressive familial intrahepatic cholestasis: insights from the NAPPED consortiumP. H. Huisman, Jernej Brecelj, Henkjan J. Verkade et al.|Journal of Hepatology|2025Cited by 0
OS-086 Event-free survival of maralixibat-treated patients with progressive familial intrahepatic cholestasis compared with aligned real-world data of untreated patients from NAPPEDPedro Miranda Afonso, Denitza Kofinova, Étienne Sokal et al.|Journal of Hepatology|2026Cited by 0
THU-284 Missense variants in the ABCB11 gene and disease severity in patients with bile salt export pump deficiencyMark Nomden, Nolwenn Laborde, Alise D. E. de Groot et al.|Journal of Hepatology|2026Cited by 0
THU-258-YI Familial intrahepatic cholestasis protein 1 (FIC1) deficiency: surgical biliary diversion improves native liver survival only in patients with relatively low serum bile acid levels in early lifeAlise D. E. de Groot, Denitza Kofinova, Mark Nomden et al.|Journal of Hepatology|2026Cited by 0